Jill Gorny Sloper

Jill Gorny Sloper

Associate

Tel. 617.994.0869
Fax 617.742.4214
Email: jgs@lahive.com

Background

Education

  • University of San Diego, B.A., Biology & Spanish, 1998
  • Creighton University, M.S., Medical Microbiology & Immunology, 2000
  • Suffolk University Law School, J.D., Intellectual Property Concentration with Distinction, 2004

Bar & Court Admissions

  • Massachusetts Bar
  • Maine Bar
  • District Court of Columbia, Court of Appeals
  • U.S. Patent and Trademark Office

Professional Involvement

  • American Intellectual Property Association
  • Boston Bar Association
  • Boston Patent Law Association
  • Massachusetts Bar Association
  • Women’s Bar Association

Honors & Awards

  • Massachusetts Super Lawyers® Rising Star List 2009

Practice Areas

Life Sciences, Patents

Industry & Technical Focus

Biotechnology, Pharmaceuticals, Microbiology, Immunology

Practice Description

Ms. Sloper assists clients with patent preparation and prosecution, validity and infringement opinions, freedom to operate, intellectual property due diligence, and oppositions involving a variety of biomedical technologies. 

Notable Experience

  • Preparing and prosecuting international patent portfolios for Medarex Inc., Novartis, Inotek Pharmaceutical Corp, and Celldex Therapeutics.
  • Conducting freedom to operate investigations for clients ranging from small biotech start-ups to established pharmaceutical companies.
  • Assessing competitive intellectual property positions and formulating responsive strategies for clients.
  • Conducting the IP due diligence for a leading gene therapy company in its $35 million Series B funding with new investors.

 

Publications & Speaking Engagements

  • Speaker, "An Overview of Terminal Disclaimers and the Impact on Patent Term Extension (PTE) and Patent Term Adjustment (PTA)," April 2010.
  • Author, Note, "The Fate of Surplus Cryopreserved Embryos: What is the Superior Alternative for their Disposition?" Suffolk University Law Review, Vol. XXXVII, No. 2. (2004)
  • Co-Author, "Pneumolysin's Role in Pneumococcal Clearance from the Bacteremic Alcoholic Host," Abstract. 31st Midwest Biomedical Research Forum. (2000)
  • Co-Author, "Clearance of Pneumococci from the Bloodstream of the Alcohol-Ingesting Host," Abstract.  10th Congress of the International Society for Biomedical Research on Alcoholism, Japan.

 

Case studies

 
 
Our Thinking Expands Yours

The client, a large pharmaceutical company, sought to build out its patent portfolio protecting an antibody drug with a potential billion-dollar global market value. » read more

News & Events

USPTO and the Federal Service for Intellectual Property, Patents and Trademarks of the Russian Federation (ROSPATENT) Launch Patent Prosecution Highway Pilot Program on September 1 » read more

Giulio A. DeConti Selected to Best Lawyers in America » read more

CAFC Invalidates Patent Covering Methods of Using Gemzar » read more

December 2, 2010
Peter Dini presents "Antibodies: Overcoming Patentability Hurdles and Claim Drafting Strategies for New Technological Developments" at the ACI Biotech Patents Conference » read more

August 30, 2010
James Velema and Peter Dini present "Patenting of Therapeutic Antibodies" to the NRC Biotechnology Research Institute, Montreal, Canada » read more

August 26, 2010
Brian Trinque presents "Nonobviousness of Chemical Inventions" at 240th ACS National Meeting » read more

Web Site Developed by  Neptune Web, Inc.